Researchers Design Needle-Free TB Vaccine That Could Transform Treatment Worldwide
Photo: Ian Talmacs / Unsplash
Johns Hopkins Medicine scientists have created an innovative nasal vaccine for tuberculosis that targets the infection's most stubborn forms. By combining two TB genes, the approach aims to help the immune system defeat drug-resistant bacteria that survive standard antibiotic treatment, offering new hope against a disease that remains the world's deadliest infectious killer.
Johns Hopkins Medicine scientists have created an innovative nasal vaccine for tuberculosis that targets the infection’s most stubborn forms. By combining two TB genes, the approach aims to help the immune system defeat drug-resistant bacteria that survive standard antibiotic treatment, offering new hope against a disease that remains the world’s deadliest infectious killer.